GE9.DE · GENMAB AS DK 1
Germany · RS rating 94 · As of 2026-10-14
| Price | 333.50 EUR |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 94 / 93 / 94 / 66 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 58 / 49 / 67 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | +491.6% |
| Sales growth Q/Q | +28.9% |
| Distance from 52-week high | +0.8% |
| Market cap (USD) | $22.6B |